BFRG Key Statistics, Chart & Performance
The current stock price of BFRG is 0.5709 USD. In the past month the price decreased by -31.28%. In the past year, price decreased by -80.04%.
BFRG Technical Analysis
BFRG Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to BFRG. BFRG scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
BFRG Financial Highlights
Over the last trailing twelve months BFRG reported a non-GAAP Earnings per Share(EPS) of -0.7. The EPS increased by 18.97% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -250.07% | ||
| ROE | -347.68% | ||
| Debt/Equity | 0.03 |
BFRG Forecast & Estimates
BFRG Ownership
BFRG Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 20.97 | 30.188B | ||
| DOCS | DOXIMITY INC-CLASS A | 15.84 | 5.221B | ||
| WAY | WAYSTAR HOLDING CORP | 14.71 | 4.649B | ||
| HTFL | HEARTFLOW INC | N/A | 2.362B | ||
| CERT | CERTARA INC | 13.02 | 1.175B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.093B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | 229.5 | 1.092B | ||
| SDGR | SCHRODINGER INC | N/A | 993.673M | ||
| TDOC | TELADOC HEALTH INC | N/A | 888.524M | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 5.53 | 828.209M |
Related stock screener links
View all stocks in the Health Care Technology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About BFRG
Company Profile
BullFrog AI Holdings, Inc. is a digital biopharmaceutical company, which engages in artificial intelligence and machine learning driven analysis of complex data sets in medicine and healthcare. The company is headquartered in Gaithersburg, Maryland and currently employs 9 full-time employees. The company went IPO on 2023-02-14. The firm is focused specifically on advanced artificial intelligence/machine learning (AI/ML) analysis of complex data in the advancement of medicine. The Company’s platform technology, bfLEAP, is an analytical AI/ML platform that is a potentially disruptive tool for the analysis of pre-clinical and/or clinical data sets, such as the robust pre-clinical and clinical trial data sets being generated in translational research and development and clinical trial settings. The platform can capture the genetic and physical characteristics of patients in an unbiased manner and contextualize them against other disparate data sources from patients. Its siRNA targets Beta2-spectrin in the treatment of human diseases, such as hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis. Mebendazole is focused on targeting Glioblastoma.
Company Info
BULLFROG AI HOLDINGS INC
325 Ellington Blvd, Unit 317
Gaithersburg MARYLAND US
Employees: 9
Phone: 12406586710
BULLFROG AI HOLDINGS INC / BFRG FAQ
Can you describe the business of BULLFROG AI HOLDINGS INC?
BullFrog AI Holdings, Inc. is a digital biopharmaceutical company, which engages in artificial intelligence and machine learning driven analysis of complex data sets in medicine and healthcare. The company is headquartered in Gaithersburg, Maryland and currently employs 9 full-time employees. The company went IPO on 2023-02-14. The firm is focused specifically on advanced artificial intelligence/machine learning (AI/ML) analysis of complex data in the advancement of medicine. The Company’s platform technology, bfLEAP, is an analytical AI/ML platform that is a potentially disruptive tool for the analysis of pre-clinical and/or clinical data sets, such as the robust pre-clinical and clinical trial data sets being generated in translational research and development and clinical trial settings. The platform can capture the genetic and physical characteristics of patients in an unbiased manner and contextualize them against other disparate data sources from patients. Its siRNA targets Beta2-spectrin in the treatment of human diseases, such as hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis. Mebendazole is focused on targeting Glioblastoma.
Can you provide the latest stock price for BULLFROG AI HOLDINGS INC?
The current stock price of BFRG is 0.5709 USD. The price increased by 14.2% in the last trading session.
Does BULLFROG AI HOLDINGS INC pay dividends?
BFRG does not pay a dividend.
What is the ChartMill rating of BULLFROG AI HOLDINGS INC stock?
BFRG has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Should I buy BFRG stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on BFRG.
How many employees does BULLFROG AI HOLDINGS INC have?
BULLFROG AI HOLDINGS INC (BFRG) currently has 9 employees.
What is the Short Interest ratio of BULLFROG AI HOLDINGS INC (BFRG) stock?
The outstanding short interest for BULLFROG AI HOLDINGS INC (BFRG) is 7.33% of its float.